|

LN-145-S1 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: TIL, autologous tumor infiltrating lymphocytes

Pipeline

Phase 2: 1

Top Sponsors

  • Iovance Biotherapeutics, Inc.1

Indications

  • Squamous Cell Carcinoma of the Head and Neck1
  • Metastatic Melanoma1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

La Jolla, California1 trial

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

University of California, San Diego

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.